AlloSure Lung dd-cfDNA Testing Service Receives Medicare Coverage
CareDx, Inc. has announced that its AlloSure Lung donor-derived cell-free DNA molecular testing service has received Medicare coverage.
CareDx, Inc. has announced that its AlloSure Lung donor-derived cell-free DNA molecular testing service has received Medicare coverage.
PathogenDx’s involvement with Operation Warp Speed, demonstrated the efficacy of microarray technology for diagnostic testing.
UCLA researchers have found a cost-effective way for early detection of cancer using cell-free DNA in blood samples.
simplSEQ, Inc. presented a poster showing the value of its technology in isolating DNA and RNA from whole blood at the 2021 AMP annual meeting.
Read MoreAsuragen Inc. has launched a testing kit for research use that is designed to detect pathogenic variants in the CFTR gene that cause cystic fibrosis.
Read MoreBiocept’s Switch-Blocker technology enhances the performance of conventional PCR-based liquid biopsy assays in detecting rare cancer mutations.
Read MoreThermo Fisher Scientific has expanded its diagnostics portfolio to support full qPCR assay development and testing workflow.
Read MoreBioGenex Laboratories announces the NanoVIP, an automated benchtop system for in situ hybridization that can run 10 different protocols simultaneously.
Read MoreIntelliseq has announced a distribution partnership with DNA ALLY to bring the IntelliseqFlow platform to the U.S.
Read MoreThermo Fisher Scientific received EUA from the FDA to run COVID-19 tests from saliva samples collected with the SpectrumDNA SDNA-1000.
Read MoreAn AI-based technology rapidly diagnoses rare disorders in critically ill children with high accuracy, foreshadowing the next phase of medicine.
Read MoreSeegene is unveiling a fully automated PCR testing system this week at the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo in Atlanta.
Read MorePerkinElmer, Inc. has announced its collaboration with the Mount Sinai Health System to increase accessibility of SARS-CoV-2 testing in New York City.
Read MoreA new sensor can detect not only whether a virus is present, but if it’s infectious – an important distinction for containing viral spread.
Read MoreMission Bio has announced two key improvements to the core capabilities of its Tapestri Platform for hematologic oncology (heme-onc) research.
Read MoreThe GENFLEX Molecular System is a high-throughput, automated, and scalable instrument for processing SARS-CoV-2 molecular diagnostic tests.
Read MoreDroplet digital PCR can detect covid-19 cases qPCR misses.
Read MoreWastewater testing—a strategy that has been used for decades by epidemiologists to track disease outbreaks—is being used to predict and stem the spread of SARS-CoV-2.
Read More